Lynne McGrath

Lynne McGrath

Director/Board Member at ALZAMEND NEURO, INC.

Net worth: 5 667 $ as of 2024-03-30

69 year
Health Technology
Consumer Services
Health Services

Profile

Lynne Fahey McGrath is an Independent Director at Alzamend Neuro, Inc. She was previously the Head of Regulatory Affairs at Novartis Oncology, Inc. from 2003 to 2015 and the Vice President of Regulatory Affairs at REGENXBIO, Inc. from 2015 to 2018.
She also served as the Global Head of Regulatory Affairs at Novartis Consumer Health.
McGrath holds a doctorate from the University of Medicine & Dentistry of New Jersey, a graduate degree from Rutgers State University of New Jersey, and an undergraduate degree from the University of Connecticut.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2023-08-23 5,667 ( 0.08% ) 5 667 $ 2024-03-30

Lynne McGrath active positions

CompaniesPositionStart
ALZAMEND NEURO, INC. Director/Board Member 2021-05-31
All active positions of Lynne McGrath

Former positions of Lynne McGrath

CompaniesPositionEnd
REGENXBIO INC. General Counsel 2018-06-30
General Counsel 2015-03-31
General Counsel -
See the detail of Lynne McGrath's experience

Training of Lynne McGrath

University of Medicine & Dentistry of New Jersey Doctorate Degree
Rutgers State University of New Jersey Graduate Degree
University of Connecticut Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Lynne McGrath's experience

Connections

56

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
REGENXBIO INC.

Health Technology

ALZAMEND NEURO, INC.

Health Technology

Private companies2

Health Technology

Health Services

See company connections
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW